Institution · BioClinica (United States)

Most cited papers from BioClinica (United States)

BioClinica (United States)

What are the most cited papers from BioClinica (United States)?

The most cited paper from BioClinica (United States) is "Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease" (Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al., 2021), with 615 citations. Next come "Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept" (554) and "A general approach to site-specific antibody drug conjugates" (320).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 61 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology Open access	22 Nov 2021	615
2	Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept D. van der Heijde, Robert Landewé, Steven G. Einstein et al. · Arthritis & Rheumatism	25 Apr 2008	554
3	A general approach to site-specific antibody drug conjugates Feng Tian et al. · Proceedings of the National Academy of Sciences Open access	17 Jan 2014	320
4	Betalainic and nutritional profiles of pigment-enriched red beet root (Beta vulgaris L.) dried extracts Boris V. Nemzer, Zbigniew J. Pietrzkowski, Aneta Spórna‐Kucab et al. · Food Chemistry	24 Dec 2010	300
5	Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer Nicola Normanno, Massimo Di Maïo, Ermelinda De Maio et al. · Endocrine Related Cancer Open access	Dec 2005	285
6	Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease Danna L. Jennings et al. · Science Translational Medicine	8 Jun 2022	266
7	Frontotemporal Connections in Episodic Memory and Aging: A Diffusion MRI Tractography Study Claudia Metzler‐Baddeley, Derek Kenton Jones, Boubakeur Belaroussi et al. · Journal of Neuroscience Open access	14 Sep 2011	259
8	Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double‐blind, placebo‐controlled study Robert G. Lambert, David Salonen, Proton Rahman et al. · Arthritis & Rheumatism	29 Nov 2007	256
9	Standardization of analysis sets for reporting results from ADNI MRI data Bradley T. Wyman et al. · Alzheimer s & Dementia Open access	27 Oct 2012	240
10	A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2 -Mutated Ovarian Carcinoma or Other Solid Tumors Rebecca Sophie Kristeleit, Geoffrey Ira Shapiro, Howard A. Burris et al. · Clinical Cancer Research	6 Mar 2017	239
11	Targeting Prodromal Alzheimer Disease With Avagacestat Vladimir Coric et al. · JAMA Neurology Open access	28 Sep 2015	236
12	A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis Roy Fleischmann, Henning Bliddal, Francisco Javier Blanco et al. · Arthritis & Rheumatology	17 Jan 2019	221
13	Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL Marco Duering, Nikola Zieren, Dominique Hervé et al. · Brain	15 Jul 2011	205
14	OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis Garry Evan Gold, Flavia Cicuttini, M.D. Crema et al. · Osteoarthritis and Cartilage Open access	May 2015	186
15	Early Invasive Cervical Cancer: CT and MR Imaging in Preoperative Evaluation—ACRIN/GOG Comparative Study of Diagnostic Performance and Interobserver Variability Hedvig Hricak, Constantine A. Gatsonis, Fergus V. Coakley et al. · Radiology	Nov 2007	173
16	Transforming Growth Factor β Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation Nina M. Muñoz, Melissa P. Upton, Andrés R. Muñoz-Rojas et al. · Cancer Research	15 Oct 2006	169
17	Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy Jerome A. Barakos, Derk D. Purcell, Joyce Suhy et al. · The Journal of Prevention of Alzheimer s Disease Open access	26 Jan 2022	165
18	OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis David John Hunter, Roy Davis Altman, Flavia Cicuttini et al. · Osteoarthritis and Cartilage Open access	May 2015	151
19	A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial Neil Binkley, Michael A. Bolognese, Anna Sidorowicz-Białynicka et al. · Journal of Bone and Mineral Research Open access	21 Mar 2012	149
20	Wavelet Approach for ECG Baseline Wander Correction and Noise Reduction Donghui Zhang Conference paper	2005	147
21	Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass Harry K. Genant, Klaus Engelke, Michael A. Bolognese et al. · Journal of Bone and Mineral Research Open access	3 Aug 2016	144
22	The EULAR–OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint B Ejbjerg, Fiona Marion McQueen, Marissa Nichole Lassere et al. · Annals of the Rheumatic Diseases Open access	12 Jan 2005	138
23	A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee Marie‐Pierre Hellio Le Graverand, R. Clemmer, Patricia Redifer et al. · Annals of the Rheumatic Diseases	10 Nov 2012	136
24	Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells Yuying Liu, Tianzhen Zhang, Haizeng Zhang et al. · Cancer Research	9 Nov 2020	135
25	Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World Srijit Seal et al. · Chemical Research in Toxicology Open access	2 May 2025	128
26	Oxygen-Sensitive Membrane Transporters in Vertebrate Red Cells John Stanley Gibson, Andrew R. Cossins, J. Clive Ellory · Journal of Experimental Biology	May 2000	124
27	Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline Jiahui Wang, Clement Vachet, Ashley Rumple et al. · Frontiers in Neuroinformatics Open access	2014	120
28	Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model Valérie Bertaina‐Anglade, Christophe Drieu La Rochelle, Pierre‐Alain Boyer et al. · Behavioural Pharmacology	18 Nov 2006	120
29	Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials Jeff Sevigny, Joyce Suhy, Ping Chiao et al. · Alzheimer Disease & Associated Disorders	2016	116
30	Measurement of Tumor Volumes Improves RECIST-Based Response Assessments in Advanced Lung Cancer P. David Mozley, Claus Bendtsen, Binsheng Zhao et al. · Translational Oncology Open access	Feb 2012	114
31	Intersubject and dose‐related variability after intravenous administration of erythromycin. KL Austin, Laurence E. Mather, C. Ross Philpot et al. · British Journal of Clinical Pharmacology Open access	Sep 1980	112
32	Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials Ronald L. Van Heertum, Robert Scarimbolo, John G. Wolodzko et al. · Drug Design Development and Therapy Open access	Jun 2017	110
33	Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics. Pieter B.M.W.M. Timmermans · Hypertension Research Open access	1999	108
34	Loss of parafibromin expression in a subset of parathyroid adenomas C. Christofer Juhlin, Catharina Larsson, T Yakoleva et al. · Endocrine Related Cancer Open access	25 May 2006	105
35	Natural cholinesterase inhibitors from marine organisms Lindon W. K. Moodie, Kristina Sepčić, Tom Turk et al. · Natural Product Reports	2019	103
36	Uncontrolled‐rate freezing and storage at –80°C, with only3.5‐percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations Pascale Halle, Olivier Tournilhac, Wanda Knopińska‐Posłuszny et al. · Transfusion	May 2001	103
37	Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA Enriqueta Felip et al. · Annals of Oncology Open access	26 Jun 2024	101
38	Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques Philip G. Conaghan, Mikkel Østergaard, M.A. Bowes et al. · Annals of the Rheumatic Diseases Open access	26 Jan 2016	101
39	Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus John Paul Bilezikian, Robert G. Josse, Richard Eastell et al. · The Journal of Clinical Endocrinology & Metabolism	Mar 2013	100
40	Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis. Jürg Reichen, Bernhard Egger, N. Ohara et al. · Journal of Clinical Investigation Open access	Dec 1988	100
41	Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease Huntington Potter, Jonathan H. Woodcock, Timothy D. Boyd et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access	2021	96
42	Biophysical and sociocultural factors underlying spatial trade-offs of ecosystem services in semiarid watersheds Marina García‐Llorente, Irene Iniesta-Arandia, Bárbara Willaarts et al. · Ecology and Society Open access	2015	94
43	Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis Evangelos Memmos, Pantelis A. Sarafidis, Panagiotis Pateinakis et al. · BMC Nephrology Open access	11 Jun 2019	89
44	Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients Nzeera Ketter, H. Robert Brashear, Jennifer Bogert et al. · Journal of Alzheimer s Disease Open access	6 Mar 2017	88
45	Low retention of HIV‐infected patients on antiretroviral therapy in 11 clinical centres in West Africa Didier Koumavi Ekouévi, Éric Balestre, Franck‐Olivier Ba‐Gomis et al. · Tropical Medicine & International Health Open access	29 Apr 2010	85
46	Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann et al. · Annals of the Rheumatic Diseases Open access	Dec 2011	84
47	Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics Daniela Bumbaca Yadav, Vikas Kumar Sharma, C. Andrew Boswell et al. · Journal of Biological Chemistry Open access	22 Oct 2015	83
48	Paracrine Proangiopoietic Effects of Human Umbilical Cord Blood-Derived Purified CD133 + Cells—Implications for Stem Cell Therapies in Regenerative Medicine Janina Ratajczak, Magda Kucia, Kasia Mierzejewska et al. · Stem Cells and Development Open access	24 Sep 2012	83
49	Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Jaime Soto, Julia T Toledo, Patrícia Gutiérrez et al. · American Journal of Tropical Medicine and Hygiene	Feb 2002	80
50	Electrophysiological studies in the post-viral fatigue syndrome. GORAN A. JAMAL, Simon Abildgaard Hansen · Journal of Neurology Neurosurgery & Psychiatry Open access	Jul 1985	78

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.